These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5765763)

  • 1. Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands.
    Svoboda D; Azarnoff D; Reddy J
    J Cell Biol; 1969 Mar; 40(3):734-46. PubMed ID: 5765763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
    Reddy JK
    Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbodies in experimentally altered cells.
    Svoboda D; Grady H; Azarnoff D
    J Cell Biol; 1967 Oct; 35(1):127-52. PubMed ID: 4964831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
    Reddy JK; Azarnoff DL; Svoboda DJ; Prasad JD
    J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbodies in experimentally altered cells. VII. CPID-induced hepatic microbody proliferation in the absence of significant catalase synthesis.
    Reddy J; Chiga M; Bunyaratvej S; Svoboda D
    J Cell Biol; 1970 Jan; 44(1):226-34. PubMed ID: 5409461
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbodies in experimentally altered cells. IX. The fate of microbodies.
    Svoboda D; Reddy J
    Am J Pathol; 1972 Jun; 67(3):541-54. PubMed ID: 4338207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New observations on microbodies. A cytochemical study on CPIB-treated rat liver.
    Legg PG; Wood RL
    J Cell Biol; 1970 Apr; 45(1):118-29. PubMed ID: 5458991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence to suggest that microbodies do not exist as individual entities.
    Reddy J; Svoboda D
    Am J Pathol; 1973 Mar; 70(3):421-38. PubMed ID: 4120301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).
    Svoboda DJ; Azarnoff DL
    J Cell Biol; 1966 Aug; 30(2):442-50. PubMed ID: 5968981
    [No Abstract]   [Full Text] [Related]  

  • 11. Proliferation of microbodies and synthesis of catalase in rat liver. Induction in tumor-bearing host by CPIB.
    Reddy J; Svoboda D
    Am J Pathol; 1971 Apr; 63(1):99-108. PubMed ID: 4323477
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on peroxisomes. V. Effect of ethyl p-chlorophenoxyisobutyrate on the centrifugal behavior of rat liver peroxisomes.
    Hayashi H; Suga T; Ninobe S
    J Biochem; 1975 Jun; 77(6):1199-204. PubMed ID: 5399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of some hypocholesterolemic agents on hepatic ulrastructure and microbody enzymes.
    Hruban Z; Mochizuki Y; Goto M; Slesers A; Chou SH
    Lab Invest; 1974 Apr; 30(4):474-85. PubMed ID: 4150963
    [No Abstract]   [Full Text] [Related]  

  • 15. [Induction of fatty acid oxidation in peroxisomes of rat liver by magnesium-4 chlorophenoxyisobutyrate (Mg-CPIB)].
    Paltauf F; Magnet K
    Arzneimittelforschung; 1979; 29(8):1132-4. PubMed ID: 583010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation kinetics of liver catalase in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate.
    Chiga M; Reddy J; Svoboda D
    Lab Invest; 1971 Jul; 25(1):49-52. PubMed ID: 5555696
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of selected hypolipidemic drugs on cell ultrastructure.
    Svoboda DJ; Azarnoff DL
    Fed Proc; 1971; 30(3):841-7. PubMed ID: 5575296
    [No Abstract]   [Full Text] [Related]  

  • 18. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    BEST MM; DUNCAN CH
    J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethyl- -p-chlorophenoxyisobutyrate induced hepatic microbody proliferation in rat liver and ubiquinone concentration.
    Reddy J; Svoboda D
    Experientia; 1971 Sep; 27(9):1059-61. PubMed ID: 5116132
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbodies in experimentally altered cells. IV. Acatalasemic (CSb) mice treated with CPIB.
    Reddy J; Bunyaratvej S; Svoboda D
    J Cell Biol; 1969 Aug; 42(2):587-96. PubMed ID: 5792343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.